ENZEEVU
Live / Applied — Third extension granted (statement of use) (as of 06 Jan 2026)
What this means for you
Not registered yet, but its 13 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98083674
- Mark type
- Stylized text
- Filed
- 13 Jul 2023
- Published for opposition
- 14 May 2024
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
Owner
- SANDOZ AG, BASEL, CH
- SANDOZ AG, BASEL, CH
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 07 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2026 — SOU EXTENSION 3 GRANTED
- 06 Jan 2026 — SOU EXTENSION 3 FILED
- 06 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2025 — SOU EXTENSION 2 GRANTED
- 07 Jul 2025 — SOU EXTENSION 2 FILED
- 07 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2025 — SOU EXTENSION 1 GRANTED
- 07 Jan 2025 — SOU EXTENSION 1 FILED
- 07 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2024 — PUBLISHED FOR OPPOSITION